Table 1 Demographic and Clinical Data for the N = 74 Total Study Population
Adolescents (n = 24) | Adults (n = 50) | Total (N = 74) | |
|---|---|---|---|
Age (years) | |||
Mean (SD) | 13.8 (1.94) | 48.4 (16.57) | 37.2 (21.27) |
Median (Min-Max) | 13 (12–17) | 50 (19–76) | 38 (12–76) |
Years since diagnosis | |||
Mean (SD) | 6.9 (4.34) | 13.3 (17.40) | 11.3 (14.86) |
Median (min-max) | 5 (2–17) | 7 (0–47) | 6 (0–47) |
Clinical severity, n (%)a | |||
Mild | 8 (33.3%) | 11 (22.4%) | 19 (26.0%) |
Moderate | 10 (41.7%) | 20 (40.8%) | 30 (41.1%) |
Severe | 6 (25.0%) | 18 (36.7%) | 24 (32.9%) |
Gender, n (%) | |||
Female | 11 (45.8%) | 27 (54.0%) | 38 (51.4%) |
Male | 13 (54.2%) | 23 (46.0%) | 36 (48.6%) |
Race, n (%) | |||
White/Caucasian | 10 (41.7%) | 27 (54.0%) | 37 (50.0%) |
Black/African American | 9 (37.5%) | 15 (30.0%) | 24 (32.4%) |
American Indian/Alaska Native | 0 (0.0%) | 2 (4.0%) | 2 (2.7%) |
Other/Unknown | 5 (20.8%) | 6 (12.0%) | 11 (14.9%) |
Ethnicity, n (%) | |||
Not Hispanic/Latino | 22 (91.7%) | 46 (92.0%) | 68 (91.9%) |
Hispanic/Latino | 2 (8.3%) | 3 (6.0%) | 5 (6.8%) |
Unknown | 0 (0.0%) | 1 (2.0%) | 1 (1.4%) |
Prior treatment, n (%) | |||
Yes | 23 (95.8%) | 43 (86.0%) | 66 (89.2%) |
No | 1 (4.2%) | 7 (14.0%) | 8 (10.8%) |
Comorbidities | |||
Allergic rhinitis, n (%) | 9 (37.5%) | 13 (26.0%) | 22 (29.7%) |
Asthma, n (%) | 8 (33.3%) | 11 (22.0%) | 19 (25.7%) |
Food allergy, n (%) | 4 (16.7%) | 12 (24.0%) | 16 (21.6%) |
Anxiety, n (%) | 0 (0.0%) | 3 (6.0%) | 3 (4.1%) |
Obesity, n (%) | 0 (0.0%) | 3 (6.0%) | 3 (4.1%) |
ADHD, n (%) | 1 (4.2%) | 1 (2.0%) | 2 (2.7%) |
Patient assessed symptom severity, n (%) | |||
Not Severe at All | 0 (0.0%) | 2 (4.0%) | 2 (2.7%) |
Very Mild | 1 (4.2%) | 7 (14.0%) | 8 (10.8%) |
Mild | 13 (54.2%) | 7 (14.0%) | 20 (27.0%) |
Moderate | 7 (29.2%) | 17 (34.0%) | 24 (32.4%) |
Severe | 2 (8.3%) | 16 (32.0%) | 18 (24.3%) |
Very Severe | 1 (4.2%) | 1 (2.0%) | 2 (2.7%) |